Alterations in biomarkers of endothelial function following on-pump coronary artery revascularization

Journal of Clinical Laboratory Analysis

Volumn 24, Issue 6, 2010, Pages 389-398

  Panagiotopoulos, Ioannis ^a   Palatianos, George ^a   Michalopoulos, Argyris ^a   Chatzigeorgiou, Antonios ^b   Prapas, Sotirios ^a   Kamper, Elli F ^b  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Angiotensin converting enzyme; Cardiopulmonary bypass; E selectin; P selectin; Tetranectin; Von Willebrand factor

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; PADGEM PROTEIN; TETRANECTIN; VON WILLEBRAND FACTOR; ACE PROTEIN, HUMAN; BIOLOGICAL MARKER; LECTIN; SELECTIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOPLEGIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY RECANALIZATION; ENDOTHELIUM; ENZYME ACTIVITY; EXTRACORPOREAL CIRCULATION; FEMALE; HUMAN; MALE; OPEN HEART SURGERY; OPERATION DURATION; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; BLOOD; CARDIOPULMONARY BYPASS; CASE CONTROL STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME; VASCULAR ENDOTHELIUM;

AGED; BIOLOGICAL MARKERS; CARDIOPULMONARY BYPASS; CASE-CONTROL STUDIES; CORONARY ARTERY BYPASS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LECTINS, C-TYPE; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; SELECTINS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME FACTORS; VON WILLEBRAND FACTOR;

EID: 78649559319     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20416     Document Type: Article

References (28)

1. Li N, Astudillo R, Ivert T, Hjemdahl P. Biphasic pro-thrombotic and inflammatory responses after coronary artery bypass surgery. J Thromb Haemost 2003;1:470-476.
2. Parolari A, Mussoni L, Frigerio M, et al. Increased prothrombotic state lasting as long as one month after on-pump and off-pump coronary surgery. J Thorac Cardiovasc Surg 2005;130:303-308.
3. Kozik DJ, Tweddell JS. Characterizing the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg 2006;81:S2347-S2354.
4. Boyle Jr EM, Pohlman TH, Johnson MC, Verrier ED. Endothelial cell injury in cardiovascular surgery: The systemic inflammatory response. Ann Thorac Surg 1997;63:277-284.
5. Constans J, Conri C. Circulating markers of endothelial function in cardiovascular disease. Clin Chim Acta 2006;368:33-47.
6. Biglioli P, Cannata A, Alamanni F, et al. Biological effects of off-pump vs. on-pump coronary artery surgery: Focus on inflammation, hemostasis and oxidative stress. Eur J Cardiothorac Surg 2003;24:260-269.
7. Podgoreanu MV, Schwinn DA. New paradigms in cardiovascular medicine: Emerging technologies and practices: Perioperative genomics. J Am Coll Cardiol 2005;46:1965-1977.
8. Davi G, Romano M, Mezzetti A, et al. Increased levels of soluble P-selectin in hypercholesterolemic patients. Circulation 1998;97:953-957.
9. Hwang SJ, Ballantyne CM, Sharrett AR, et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk In Communities (ARIC) study. Circulation 1997;96:4219-4225.
10. Blann AD, Nadar SK, Lip GY. The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J 2003;24:2166-2179.
11. Nielsen H, Clemmensen I, Kharazmi A. Tetranectin: A novel secretory protein from human monocytes. Scand J Immunol 1993;37:39-42.
12. Graversen JH, Lorentsen RH, Jacobsen C, et al. The plasminogen binding site of the C-type lectin tetranectin is located in the carbohydrate recognition domain, and binding is sensitive to both calcium and lysine. J Biol Chem 1998;273:29241-29246.
13. Mogues T, Etzerodt M, Hall C, Engelich G, Graversen JH, Hartshorn KL. Tetranectin binds to the Kringle 1-4 form of angiostatin and modifies its functional activity. J Biomed Biotechnol 2004;73-78.
14. Lip GY, Blann A. von Willebrand factor: A marker of endothelial dysfunction in vascular disorders? Cardiovasc Res 1997;34:255-265.
15. Fleming I. Signaling by the angiotensin-converting enzyme. Circ Res 2006;98:887-896.
16. Ribichini F, Steffenino G, Dellavalle A, et al. Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme: A major risk factor and a marker of risk for coronary stent restenosis. Circulation 1998;97:147-154.
17. Mylona-Karayanni C, Gourgiotis D, Bossios A, Kamper EF. Oxidative stress and adhesion molecules in children with type 1 diabetes mellitus: A possible link. Pediatr Diabetes 2006;7:51-59.
18. Holdright DR, Hunt BJ, Parratt R, et al. The effects of cardiopulmonary bypass on systemic and coronary levels of von Willebrand factor. Eur J Cardiothorac Surg 1995;9:18-21.
19. Eikemo H, Sellevold OF, Videm V. Markers for endothelial activation during open heart surgery. Ann Thorac Surg 2004;77:214-219.
20. Paret G, Prince T, Keller N, et al. Plasma-soluble E-selectin after cardiopulmonary bypass in children: Is it a marker of the postoperative course? J Cardiothorac Vasc Anesth 2000;14:433-437.
21. Napoleao P, Santos MC, Selas M, Viegas-Crespo AM, Pinheiro T, Ferreira RC. Variations in inflammatory markers in acute myocardial infarction: A longitudinal study. Rev Port Cardiol 2007;26:1357-1363.
22. Galea J, Rebuck N, Finn A, Manche A, Moat N. Expression of soluble endothelial adhesion molecules in clinical cardiopulmonary bypass. Perfusion 1998;13:314-321.
23. Jansson JH, Nilsson TK, Johnson O. von Willebrand factor in plasma: A novel risk factor for recurrent myocardial infarction and death. Br Heart J 1991;66:351-355.
24. Kamper EF, Kopeikina L, Mantas A, Stefanadis C, Toutouzas P, Stavridis J. Tetranectin levels in patients with acute myocardial infarction and their alterations during thrombolytic treatment. Ann Clin Biochem 1998;35:400-407.
25. Kopeikina LT, Kamper EF, Mantas A, Kremastinos D, Stavridis J. Plasma tetranectin levels in patients with unstable and stable angina. Fibrinolysis Proteolysis 1998;12:353-359.
26. Hoshida S, Kato J, Nishino M, et al. Increased angiotensin-converting enzyme activity in coronary artery specimens from patients with acute coronary syndrome. Circulation 2001;103:630-633.
27. Shreeniwas R, Koga S, Karakurum M, et al. Hypoxia-mediated induction of endothelial cell interleukin-1 alpha. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface. J Clin Invest 1992;90:2333-2339.
28. Scheurer SB, Rybak JN, Rosli C, Neri D, Elia G. Modulation of gene expression by hypoxia in human umbilical cord vein endothelial cells: A transcriptomic and proteomic study. Proteomics 2004;4:1737-1760.